The use of porcupine inhibitors to target Wnt-driven cancers

Area of Science:

• Oncology
• Molecular Biology
• Drug Discovery

Background:

• The Wnt pathway is crucial in cellular processes and implicated in various cancers.
• Intervention strategies are being developed to modulate Wnt signaling.
• Porcupine (PORCN), a membrane-bound O-acyl transferase, is a key regulator of Wnt ligand secretion.

Purpose of the Study:

• To review small molecule inhibitors targeting PORCN.
• To discuss the therapeutic potential of PORCN inhibitors in Wnt-driven cancers.
• To explore human disease models responsive to PORCN inhibition.

Main Methods:

• Literature review of published research on PORCN inhibitors.
• Analysis of drug discovery efforts targeting PORCN.
• Examination of preclinical and clinical data for PORCN inhibitor efficacy.

Main Results:

• Several small molecule inhibitors targeting PORCN have been identified.
• These inhibitors demonstrate potential in blocking Wnt ligand secretion.
• Progress has been made in identifying cancer models sensitive to PORCN inhibition.

Conclusions:

• PORCN inhibitors represent a promising therapeutic strategy for Wnt-driven cancers.
• Further research is needed to optimize these inhibitors and validate their clinical utility.
• PORCN inhibition holds potential for treating various malignancies.